Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interspecies extrapolation in risk analysis.

C C Travis1

  • 1Health and Safety Research Division, Oak Ridge National Laboratory.

Annali Dell'Istituto Superiore Di Sanita
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer risk management A review of 132 federal regulatory decisions.

Environmental science & technology·2012
Same author

Bioconcentration of organics in beef, milk, and vegetation.

Environmental science & technology·2012
Same author

Determining an acceptable level of risk.

Environmental science & technology·2011
Same author

Drinking-water standards.

Environmental science & technology·2011
Same author

Effectiveness of Purge-and-Trap for Measurement of Volatile Organic Compounds in Aged Soils.

Analytical chemistry·2011
Same author

The genomic revolution: what does it mean for risk assessment?

Risk analysis : an official publication of the Society for Risk Analysis·2002
Same journal

External quality assessment programs in cytogenomics in the Lombardy Region, Italy (2018-2024): performance and trends.

Annali dell'Istituto superiore di sanita·2026
Same journal

Spontaneous orienting of untrained companion dogs naïve to human epilepsy toward odor samples from an unfamiliar human in a controlled non-social paradigm: a proof-of-concept.

Annali dell'Istituto superiore di sanita·2026
Same journal

Addressing food and nutrition insecurity in European countries: a scoping review of strategies and policies.

Annali dell'Istituto superiore di sanita·2026
Same journal

Women's experiences of membrane sweeping for labour induction: a phenomenological qualitative study.

Annali dell'Istituto superiore di sanita·2026
Same journal

Evaluating the usefulness of the Mediterranean Diet Quality Index (KIDMED) in assessing eating habits and nutritional status among preschool children.

Annali dell'Istituto superiore di sanita·2026
Same journal

Optimizing sample preparation for homogeneous mycotoxin distribution in official control analyses.

Annali dell'Istituto superiore di sanita·2026
See all related articles

Accurately extrapolating animal study results to humans is crucial for cancer risk assessment. The 3/4 power of body weight is recommended as the most reliable method for interspecies scaling when specific data is unavailable.

Area of Science:

  • Toxicology and Pharmacology
  • Risk Assessment
  • Comparative Physiology

Background:

  • Interspecies extrapolation of experimental data is a fundamental challenge in cancer risk assessment.
  • Current methods often rely on body weight (1st power) or surface area (2/3 power) scaling, which are approximations.
  • Lack of specific pharmacokinetic data necessitates reliable general extrapolation methods.

Purpose of the Study:

  • To evaluate the accuracy of different interspecies scaling methods for extrapolating experimental results.
  • To identify the most appropriate scaling metric for risk assessment in the absence of compound-specific data.
  • To provide evidence supporting a refined approach to interspecies extrapolation.

Main Methods:

  • Analysis of allometric scaling principles and physiological parameter scaling.

Related Experiment Videos

  • Examination of physiologically-based pharmacokinetics (PBPK) and its role in interspecies extrapolation.
  • Comparative analysis of clearance and half-life data for various compounds across multiple species.

    • Main Results:

    • Neither body weight (1st power) nor surface area (2/3 power) scaling is universally accurate for all compounds.
    • The 3/4 power of body weight scaling law demonstrated a more accurate estimation of a compound's true scaling metric.
    • Analysis of clearance and half-life data supported the superiority of the 3/4 power scaling law.

    Conclusions:

    • The 3/4 power of body weight is the recommended interspecies scaling metric when specific pharmacokinetic data or mechanism of action is unknown.
    • This method offers a more accurate approach to extrapolating experimental findings between species for risk assessment.
    • Utilizing the most appropriate scaling metric improves the reliability of cancer risk assessment and regulatory decision-making.